BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 18413727)

  • 1. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells.
    Chan SW; Lim CJ; Guo K; Ng CP; Lee I; Hunziker W; Zeng Q; Hong W
    Cancer Res; 2008 Apr; 68(8):2592-8. PubMed ID: 18413727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
    Liu CY; Yu T; Huang Y; Cui L; Hong W
    J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
    Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
    Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells.
    Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K
    Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRTF/SRF dependent transcriptional regulation of TAZ in breast cancer cells.
    Liu CY; Chan SW; Guo F; Toloczko A; Cui L; Hong W
    Oncotarget; 2016 Mar; 7(12):13706-16. PubMed ID: 26885614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiomotin promotes breast cancer cell proliferation and invasion.
    Lv M; Lv M; Chen L; Qin T; Zhang X; Liu P; Yang J
    Oncol Rep; 2015 Apr; 33(4):1938-46. PubMed ID: 25647626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
    Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
    Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ.
    Zhang Z; Du J; Wang S; Shao L; Jin K; Li F; Wei B; Ding W; Fu P; van Dam H; Wang A; Jin J; Ding C; Yang B; Zheng M; Feng XH; Guan KL; Zhang L
    Mol Cell; 2019 Jan; 73(1):7-21.e7. PubMed ID: 30472188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin.
    Gao Y; Chen X; He Q; Gimple RC; Liao Y; Wang L; Wu R; Xie Q; Rich JN; Shen K; Yuan Z
    Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33295-33304. PubMed ID: 33318171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen regulates Hippo signaling via GPER in breast cancer.
    Zhou X; Wang S; Wang Z; Feng X; Liu P; Lv XB; Li F; Yu FX; Sun Y; Yuan H; Zhu H; Xiong Y; Lei QY; Guan KL
    J Clin Invest; 2015 May; 125(5):2123-35. PubMed ID: 25893606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAPCD2 promotes invasiveness and migration ability of breast cancer cells via YAP/TAZ.
    Zhang Y; Liu JL; Wang J
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3786-3794. PubMed ID: 32329855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TAZ-miR-224-SMAD4 axis promotes tumorigenesis in osteosarcoma.
    Ma J; Huang K; Ma Y; Zhou M; Fan S
    Cell Death Dis; 2017 Jan; 8(1):e2539. PubMed ID: 28055015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
    Nagashima S; Maruyama J; Honda K; Kondoh Y; Osada H; Nawa M; Nakahama KI; Ishigami-Yuasa M; Kagechika H; Sugimura H; Iwasa H; Arimoto-Matsuzaki K; Nishina H; Hata Y
    J Biol Chem; 2021 Jul; 297(1):100803. PubMed ID: 34022224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Prolyl isomerase Pin1 as a novel positive regulator of YAP/TAZ in breast cancer cells.
    Khanal P; Yeung B; Zhao Y; Yang X
    Sci Rep; 2019 Apr; 9(1):6394. PubMed ID: 31015482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
    Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization.
    Zhao X; Wang X; You Y; Wen D; Feng Z; Zhou Y; Que K; Gong J; Liu Z
    Exp Cell Res; 2020 Jun; 391(1):111979. PubMed ID: 32246992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of transcriptional coactivator TAZ in gliomas.
    Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
    Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor‑β‑mediated epithelial‑mesenchymal transition.
    Zhang Q; Han M; Wang W; Song Y; Chen G; Wang Z; Liang Z
    Oncol Rep; 2015 Apr; 33(4):1851-9. PubMed ID: 25632968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation.
    Matsushita A; Sato T; Mukai S; Fujishita T; Mishiro-Sato E; Okuda M; Aoki M; Hasegawa Y; Sekido Y
    Oncogene; 2019 Mar; 38(11):1966-1978. PubMed ID: 30401981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27.
    Wan M; Huang W; Kute TE; Miller LD; Zhang Q; Hatcher H; Wang J; Stovall DB; Russell GB; Cao PD; Deng Z; Wang W; Zhang Q; Lei M; Torti SV; Akman SA; Sui G
    Am J Pathol; 2012 May; 180(5):2120-33. PubMed ID: 22440256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.